Skip to main content
Explore URMC

Andrea C. Wasilewski, M.D.

Contact Information

Phone Numbers

Appointment: (585) 275-5863

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Setting



Andrea Wasilewski MD is a board certified neurologist and neuro-oncologist with a passion for providing the highest quality patient care. She is also a clinical researcher and medical educator. Dr. Wasilewski specializes in treating patients with primary brain cancer, primary central nervous system lymphoma, brain metastases and neurologic complications of cancer. Her treatment philosophy emphasizes comprehensive and multifaceted approaches to cancer care for patients and their caregivers. As a clinical researcher Dr. Wasilewski develops and studies new ways of evaluating and treating older patients with brain cancer.



  • Neurology - General - American Board of Psychiatry and Neurology


MD | Jagiellonian University Medical College, Faculty of Medicine

Post-doctoral Training & Residency

07/01/2018 - 06/30/2019
Fellowship in Neuro-Oncology at University of Rochester Medical Center

06/10/2014 - 6/30/2015
Internship in Neurology at University of Rochester Medical Center

7/1/2015 - 6/30/2018
Residency in Neurology at University of Rochester Medical Center

VIEW ALL expand_more


American Academy of Neurology Fellow Scholarship
Sponsor: American Academy of Neurology

Clinical Trials

A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma

Lead Researcher: Andrea C Wasilewski

This phase II/III trial compares the usual treatment with radiation therapy and temozolomide to radiation therapy in combination with immunotherapy with ipilimumab and nivolumab in treating patients with newly diagnosed MGMT unmethylated glioblastoma. Radiation therapy uses high energy photons to kill tumor and shrink tumors. Chemotherapy drugs, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Temozolomide, may not work as well for the treatment of tumors that have the unmethylated MGMT. Immunotherapy with monoclonal antibodies called immune checkpoint inhibitors, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. It is possible that immune checkpoint inhibitors may work better at time of first diagnosis as opposed to when tumor comes back. Giving radiation therapy with ipilimumab and nivolumab may lengthen the time without brain tumor returning or growing and may extend patients' life compared to usual treatment with radiation therapy and temozolomide.

View Study Details

Comprehensive Geriatric Assessment in Older Patients with Newly Diagnosed Malignant Gliomas

Lead Researcher: Andrea C Wasilewski

The purpose of this study is to collect information about the physical function, thinking, independence, social support, and medications of older patients with brain tumors in order to develop more specialized treatments and support for that population. Inclusion Criteria: Age 65 or older of any race, ethnicity, or gender; Pathologically confirmed glioblastoma or anaplastic astrocytoma; Have not started radiation or chemotherapy for brain tumor treatment

View Study Details


Journal Articles

Saleh C, Jaszczuk P, Hund-Georgiadis M, Frank S, Cordier D, Bratic Hench I, Todea A, Wasilewski A, Wilmes S, Grigioni G, Hench J. "Differentiation of rare brain tumors through unsupervised machine learning: Clinical significance of in-depth methylation and copy number profiling illustrated through an unusual case of IDH wildtype glioblastoma." Clinical neuropathology.. 2020 Sep 1; Epub 2020 Sep 01.

Wasilewski A, Alam A, Mohile N. "Chemotherapy toxicities and geriatric syndromes in older patients with malignant gliomas." Journal of geriatric oncology.. 2020 Jul 13; Epub 2020 Jul 13.

Wasilewski A, Mohile N. "Meet the expert: How I treat chemotherapy-induced peripheral neuropathy." Journal of geriatric oncology.. 2020 Jun 16; Epub 2020 Jun 16.